Topics Buzzing stocks | Hikal | Markets

SI Reporter  |  Mumbai  Last Updated at June 3, 2022 14:13 IST

Shares of Hikal hit a fresh 52-week low of Rs 303.50, down 4 per cent on the BSE in Friday’s trade. The stock of the company has fallen 21 per cent in the last one week after the firm reported a weak set of numbers for the quarter ended March 2022 (Q4FY22). In comparison, at 01:50 pm, the S&P BSE Sensex was up 0.5 per cent at 56,090 points.

With the past one week's decline, the stock of the pharmaceutical company has corrected 59 per cent from its record high level of Rs 742 touched on August 17, 2021.

In Q4, Hikal’s consolidated profit after tax (PAT) declined 59 per cent year on year (YoY) to Rs 21 crore, due to higher operational cost and lower revenue. The company had posted a PAT of Rs 51 crore in the year-ago quarter. Earnings before interest, taxes, depreciation, and amortization (EBITDA) contracted by 834 bps to 12.15 per cent from 20.49 per cent in Q4FY21.

The company’s revenue was down 5.6 per cent to Rs 502 crore from Rs 532 crore last year. The pharmaceutical segment recorded muted 3 per cent YoY revenue growth at Rs 308 crore due to demand softening and lower off-take by the customers. The crop protection segment de-grew by 17 per cent YoY to Rs 194 crore.

The muted revenue growth in pharmaceutical business was in line with the recent trend witnessed by the API industry due to strong transient headwinds of softening demand and disruptions in global supply chains. This combined with the challenging raw material disruptions and significant increase in input costs has seen a pressure on margins in Q4, which the management expects to continue through the first half of the year.

"As the industry faces strong headwinds due to the inflationary pressures and a sharp rise in input costs of raw material, energy and solvents, we expect growth to be tapered and margins to be contract in the current fiscal", the management said.

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request. As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed. Support quality journalism and subscribe to Business Standard . Digital Editor

Copyrights © 2022 Business Standard Private Ltd. All rights reserved.

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

Welcome to the premium services of Business Standard brought to you courtesy FIS. Kindly visit the Manage my subscription page to discover the benefits of this programme. Enjoy Reading! Team Business Standard